1. Buss NAPS, Henderson SJ, McFarlane M, Shenton JM, de Haan L (2012) Monoclonal antibody therapeutics: history and future. Curr. Opin. Pharmacol, 12(5), 615. doi: 10.1016/j.coph.2012.08.001.
2. Frenzel A, Fröde D, Meyer T, Schirrmann T, Hust M (2012) Generating Recombinant Antibodies for Research, Diagnostics and Therapy Using Phage Display. Curr. Biotechnol. 1, 33–41. doi:10.2174/22111550111201010033
3. Lipman NS, Jackson LR, Trudel LJ, Weis-Garcia F (2005) Monoclonal Versus Polyclonal Antibodies: Distinguishing Characteristics, Applications, and Information Resources. ILAR J. 46(3), 258–268. doi:10.1093/ilar.46.3.258
4. Boado RJ, Zhang Y, Zhang Y, Xia CF, Pardridge WM (2007) Fusion antibody for Alzheimer's disease with bidirectional transport across the blood-brain barrier and abeta fibril disaggregation. Bioconjugate Chem. 18(2): , 447–55. doi: 10.1021/bc060349x.
5. Cao M, Cao P, Yan H, Lu W, Ren F, et al.. (2009) Construction, purification, and characterization of anti-BAFF scFv-Fc fusion antibody expressed in CHO/dhfr- cells. Appl Biochem Biotechnol. 157(3): , 562–74. doi: 10.1007/s12010-008-8434-6.